Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yoshie Shiraga"'
Autor:
Naoya Osaka, Yusaku Mori, Michishige Terasaki, Munenori Hiromura, Tomomi Saito, Hironori Yashima, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Sho-ichi Yamagishi
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective Sodium-glucose cotransporter-2 (SGLT2) inhibitors exhibit cardioprotective properties in patients with diabetes. However, SGLT2 is not expressed in the heart, and the underlying molecular mechanisms are not fully understood. We investigated
Externí odkaz:
https://doaj.org/article/70384bedcd3a41af9453288197520c36
Autor:
Michishige Terasaki, Hironori Yashima, Yusaku Mori, Tomomi Saito, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Tsutomu Hirano, Yuichiro Yamada, Yutaka Seino, Sho-ichi Yamagishi
Publikováno v:
Biomedicines, Vol 9, Iss 7, p 832 (2021)
Glucose-dependent insulinotropic polypeptide (GIP) has been reported to have an atheroprotective property in animal models. However, the effect of GIP on macrophage foam cell formation, a crucial step of atherosclerosis, remains largely unknown. We i
Externí odkaz:
https://doaj.org/article/a05162f7f8d34e2680a4617c06428ef7
Autor:
Michishige Terasaki, Yusaku Mori, Hironori Yashima, Tomomi Saito, Ami Sotokawauchi, Takanori Matsui, Munenori Hiromura, Naoya Osaka, Ayako Fukase, Raichi Kawakami, Yoshie Shiraga, Makoto Ohara, Tomoyasu Fukui, Shoichi Yamagishi
Publikováno v:
Journal of Hypertension. 41:e272
Autor:
Yoshie Shiraga, Yusaku Mori, Makoto Ohara, Sho-ichi Yamagishi, Yutaka Seino, Hironori Yashima, Yuichiro Yamada, Tomoyasu Fukui, Tomomi Saito, Raichi Kawakami, Michishige Terasaki, Tsutomu Hirano
Publikováno v:
Biomedicines
Volume 9
Issue 7
Biomedicines, Vol 9, Iss 832, p 832 (2021)
Volume 9
Issue 7
Biomedicines, Vol 9, Iss 832, p 832 (2021)
Glucose-dependent insulinotropic polypeptide (GIP) has been reported to have an atheroprotective property in animal models. However, the effect of GIP on macrophage foam cell formation, a crucial step of atherosclerosis, remains largely unknown. We i
Autor:
Naoya Osaka, Yusaku Mori, Michishige Terasaki, Munenori Hiromura, Tomomi Saito, Hironori Yashima, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Sho-ichi Yamagishi
Publikováno v:
Journal of International Medical Research. 50:030006052210974
Objective Sodium-glucose cotransporter-2 (SGLT2) inhibitors exhibit cardioprotective properties in patients with diabetes. However, SGLT2 is not expressed in the heart, and the underlying molecular mechanisms are not fully understood. We investigated